JP2002542253A - 新規のリボース置換芳香族アミド、それらの製造方法及びそれらの薬剤としての使用 - Google Patents

新規のリボース置換芳香族アミド、それらの製造方法及びそれらの薬剤としての使用

Info

Publication number
JP2002542253A
JP2002542253A JP2000612312A JP2000612312A JP2002542253A JP 2002542253 A JP2002542253 A JP 2002542253A JP 2000612312 A JP2000612312 A JP 2000612312A JP 2000612312 A JP2000612312 A JP 2000612312A JP 2002542253 A JP2002542253 A JP 2002542253A
Authority
JP
Japan
Prior art keywords
methyl
formula
compound
group
benzopyran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000612312A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002542253A5 (cg-RX-API-DMAC7.html
Inventor
デマセ ジャック
クリク ミシェル
ムシキ ブラニスラフ
Original Assignee
アベンティス ファルマ ソシエテ アノニム
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アベンティス ファルマ ソシエテ アノニム filed Critical アベンティス ファルマ ソシエテ アノニム
Publication of JP2002542253A publication Critical patent/JP2002542253A/ja
Publication of JP2002542253A5 publication Critical patent/JP2002542253A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/075—Benzo[b]pyran-2-ones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP2000612312A 1999-04-19 2000-04-18 新規のリボース置換芳香族アミド、それらの製造方法及びそれらの薬剤としての使用 Pending JP2002542253A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR99/04866 1999-04-19
FR9904866A FR2792320B1 (fr) 1999-04-19 1999-04-19 Nouveaux amides aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
PCT/FR2000/000999 WO2000063222A2 (fr) 1999-04-19 2000-04-18 Nouveaux amides aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
JP2002542253A true JP2002542253A (ja) 2002-12-10
JP2002542253A5 JP2002542253A5 (cg-RX-API-DMAC7.html) 2007-01-11

Family

ID=9544554

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000612312A Pending JP2002542253A (ja) 1999-04-19 2000-04-18 新規のリボース置換芳香族アミド、それらの製造方法及びそれらの薬剤としての使用

Country Status (24)

Country Link
US (1) US6579902B1 (cg-RX-API-DMAC7.html)
EP (1) EP1173455A2 (cg-RX-API-DMAC7.html)
JP (1) JP2002542253A (cg-RX-API-DMAC7.html)
KR (1) KR100693258B1 (cg-RX-API-DMAC7.html)
CN (1) CN1213055C (cg-RX-API-DMAC7.html)
AP (1) AP2001002312A0 (cg-RX-API-DMAC7.html)
AU (1) AU769514B2 (cg-RX-API-DMAC7.html)
CA (1) CA2363945A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20013708A3 (cg-RX-API-DMAC7.html)
EA (1) EA004304B1 (cg-RX-API-DMAC7.html)
FR (1) FR2792320B1 (cg-RX-API-DMAC7.html)
HK (1) HK1046690B (cg-RX-API-DMAC7.html)
HU (1) HUP0200778A3 (cg-RX-API-DMAC7.html)
ID (1) ID30562A (cg-RX-API-DMAC7.html)
IL (1) IL146018A0 (cg-RX-API-DMAC7.html)
NO (1) NO320703B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ515108A (cg-RX-API-DMAC7.html)
PL (1) PL354192A1 (cg-RX-API-DMAC7.html)
SK (1) SK14842001A3 (cg-RX-API-DMAC7.html)
TR (1) TR200103009T2 (cg-RX-API-DMAC7.html)
UA (1) UA72919C2 (cg-RX-API-DMAC7.html)
WO (1) WO2000063222A2 (cg-RX-API-DMAC7.html)
YU (1) YU80301A (cg-RX-API-DMAC7.html)
ZA (1) ZA200108627B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2844273B1 (fr) * 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
KR100649357B1 (ko) * 2004-05-04 2006-11-24 제일약품주식회사 항염증 활성을 갖는 크로멘-2-온 모핵 히드록사민 산유도체, 이의 제조방법 및 이를 포함하는 염증 질환의치료를 위한 조성물
US7622451B2 (en) * 2004-11-03 2009-11-24 University Of Kansas Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
AU2005301957B2 (en) * 2004-11-03 2012-02-23 Department Of Health And Human Services Novobiocin analogues as anticancer agents
US9120774B2 (en) 2004-11-03 2015-09-01 University Of Kansas Novobiocin analogues having modified sugar moieties
US8212011B2 (en) * 2004-11-03 2012-07-03 University Of Kansas Novobiocin analogues
US8212012B2 (en) * 2004-11-03 2012-07-03 University Of Kansas Novobiocin analogues having modified sugar moieties
US7960353B2 (en) * 2007-05-10 2011-06-14 University Of Kansas Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
WO2010014617A1 (en) * 2008-07-28 2010-02-04 University Of Kansas Heat shock protein 90 inhibitor dosing methods
US20110082098A1 (en) * 2009-09-30 2011-04-07 University Of Kansas Novobiocin analogues and treatment of polycystic kidney disease
MX2025007723A (es) 2018-05-14 2025-08-01 Reata Pharmaceuticals Inc Biarilamidas con grupos de azucar modificados para el tratamiento de enfermedades asociadas con la trayectoria de la proteina de choque de calor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890297A (en) * 1973-03-29 1975-06-17 Upjohn Co Process for n-acylating novenamine
JPS5231432B1 (cg-RX-API-DMAC7.html) * 1969-06-02 1977-08-15

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231432B1 (cg-RX-API-DMAC7.html) * 1969-06-02 1977-08-15
US3890297A (en) * 1973-03-29 1975-06-17 Upjohn Co Process for n-acylating novenamine

Also Published As

Publication number Publication date
EA200101100A1 (ru) 2002-04-25
SK14842001A3 (sk) 2003-05-02
HK1046690B (zh) 2006-03-10
WO2000063222A2 (fr) 2000-10-26
NO320703B1 (no) 2006-01-16
YU80301A (sh) 2005-07-19
UA72919C2 (uk) 2005-05-16
FR2792320A1 (fr) 2000-10-20
CZ20013708A3 (cs) 2002-04-17
WO2000063222A3 (fr) 2001-05-31
NO20015058L (no) 2001-12-17
ZA200108627B (en) 2002-10-21
AU769514B2 (en) 2004-01-29
HUP0200778A3 (en) 2003-03-28
CN1213055C (zh) 2005-08-03
KR100693258B1 (ko) 2007-03-13
PL354192A1 (en) 2003-12-29
FR2792320B1 (fr) 2003-05-09
IL146018A0 (en) 2002-07-25
CA2363945A1 (fr) 2000-10-26
ID30562A (id) 2001-12-20
CN1357001A (zh) 2002-07-03
TR200103009T2 (tr) 2002-05-21
US6579902B1 (en) 2003-06-17
EA004304B1 (ru) 2004-02-26
KR20020008155A (ko) 2002-01-29
NZ515108A (en) 2004-01-30
HK1046690A1 (en) 2003-01-24
AU4125600A (en) 2000-11-02
AP2001002312A0 (en) 2001-12-31
EP1173455A2 (fr) 2002-01-23
HUP0200778A2 (hu) 2002-07-29
NO20015058D0 (no) 2001-10-18

Similar Documents

Publication Publication Date Title
EP1234833B1 (en) Preparation of crystalline azithromycin dihydrate.
JP2002500229A (ja) 新規な芳香族アミド、調製方法及び薬剤としての用途
JP2001507714A (ja) 三環式エリスロマイシン誘導体
US9765105B2 (en) Macrolide compound
HK1040083A1 (en) Avermectin derivatives
US6579902B1 (en) Ribose-substituted aromatic amides, method for the production and use thereof as medicaments
JP2002502366A (ja) 3―デスクラジノース―2,3―無水エリスロマイシン誘導体
EP3406619A1 (en) Method and intermediate for preparing tulathromycin
CA2258152C (fr) Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
EP1284984B1 (fr) Derives de l'uridine comme antibiotiques
JPH05239086A (ja) 8a−アザ−8a−ホモエリスロマイシン環式ラクタム
JP2001506620A (ja) 新規なエリスロマイシン誘導体、それらの製造方法及びそれらの医薬としての利用
AU2013320407A1 (en) Macrolide derivatives, preparation thereof and therapeutic use thereof
ES2237828T3 (es) Nuevos derivados aromaticos sustituidos con una ribosa, su procedimiento de preparacion y su aplicacion como medicamentos.
AU2002300839B2 (en) Novel aromatic amides, preparation method and application as medicines
JP2003535100A (ja) 細菌および原虫類感染症の治療用ハイグロマイシンa誘導体
JPS6152160B2 (cg-RX-API-DMAC7.html)
MXPA01010624A (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
KR100466988B1 (ko) 리보오스치환된신규방향족유도체들,이들의제조방법및의약으로서의용도
CS199728B2 (en) Method of producing derivatives of 4"-sulphonyl amino oleandomycin
FR2784681A1 (fr) Nouveaux amides aromatiques, leur procede de preparation et leur application comme medicaments
FR2773369A1 (fr) Nouveaux amides aromatiques, leur procede de preparation et leur application comme medicaments

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061115

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061115

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080911

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100420

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101005